Sciensus’ unique aseptic compounding pharmacy proposition
State-of-the-art capabilities for even the most complex therapies
Healthcare providers are facing rising demand for aseptic medicines, particularly in oncology, driven by increased diagnoses, innovative therapies and expanding treatment options.
Sciensus’ aseptic compounding pharmacy service is built to meet the growing demand for safe, sterile medications in a healthcare environment under pressure.
Improved patient access
Operational efficiency
Enhanced compliance and safety
Accelerating the reach of today’s complex medicines across Europe
At the heart of our service is our purpose-built aseptic compounding unit, completed in 2020. Fully MHRA licensed, the facility prepares sterile, personalised medications across more than 400 regimens and 137 molecules, including many new immunotherapies. Treatments are delivered safely to both hospitals and patients’ homes, supported by our national nursing network.
-
Advanced aseptic preparation
-
End-to-end delivery
-
Clinical expertise
Ready to meet oncology demand without compromising safety?
Get in touch to use our advanced compounding unit and clinical expertise to become an extension of your service
Sciensus’ aseptic compounding pharmacy service is built to meet the growing demand for safe, sterile medications in a healthcare environment under pressure. Patient needs are evolving, particularly in oncology where innovation and diagnosis are rapidly expanding treatment opportunities.
Our fully MHRA-licensed compounding unit, opened in 2020, leverages the latest assurance practices and technology to deliver sterile, tailored medications. These treatments are supplied not only to NHS and private hospitals for in-clinic use but also directly to patients’ homes, supported by our specialist nursing team.
Key features of our unit include hydrogen peroxide gassing, continuous environmental sampling, volumetric and gravimetric controls and a fully paperless system. Together, these measures safeguard patient safety and product integrity.
By combining this expertise with a robust GDP-compliant distribution network and our collaborative partnerships with biopharma companies, Sciensus enables healthcare providers to improve efficiency, reduce cost pressures and expand access to life-changing therapies.
Purpose-built capacity
Customisable solutions
Strong pharma partnerships
Frequently asked questions
What is aseptic compounding?
Aseptic compounding is the preparation of sterile medications in a controlled environment to prevent contamination. It ensures treatments remain free from bacteria, viruses and other pathogens – critical for patients with weakened immune systems, such as those undergoing chemotherapy.
What types of medications can Sciensus prepare?
We supply over 400 treatment regimens covering more than 125 molecules, including many new immunotherapies, tailored and sterile to meet individual patient needs.
How quickly can Sciensus deliver compounded medicines?
Thanks to our GDP-compliant distribution network, we can deliver to any UK hospital site within five working days, meeting all temperature requirements from ambient to -90°C.
How does Sciensus ensure safety and compliance?
Our aseptic compounding unit is fully MHRA-licensed and operates with continuous environmental monitoring, advanced sterilisation techniques and strict quality assurance practices.
Can patients receive treatment at home?
Yes. Many medications prepared in our unit are administered to patients in their own homes by our national team of specially trained nurses, helping providers reduce clinical pressures and improve patient experience.
Meet our compounding expert
Get in touch
Thank you for your interest in Sciensus. Whether you’re seeking information, partnership opportunities, or want to refer a patient, our dedicated team is here to assist you. Please fill out the form on the right, and one of our multi-lingual representatives will get in touch with you promptly.